Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Ongoing and Intensified Molecular Testing Education Needed Globally

Key clinical point: Continuous education around molecular testing should be intensified to ensure that patients receive optimal therapy.

Major finding: A third of respondents reported being unaware of updated guidelines on molecular testing for lung cancer.

Study details: A survey of 2,537 specialists.

Disclosures: The IASLC survey was funded by AstraZeneca. Dr. Smeltzer reported receiving research support from the Bristol Myers Squibb Foundation.


Smeltzer M et al. WCLC 2019, Abstract PR01.05.